Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 50551-50600 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05233787
Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17)
NA
Recruiting
212 participants
Started: Mar 24, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
28 locations
NCT05095649
Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib
PHASE2
Recruiting
15 participants
Started: Mar 24, 2022 · Completed: Feb 15, 2026
1 condition
1 sponsor
1 location
NCT05477576
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
PHASE3
Recruiting
288 participants
Started: Mar 24, 2022 · Completed: Jul 31, 2028
7 conditions
1 sponsor
53 locations
NCT04162938
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
NA
Recruiting
308 participants
Started: Mar 24, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05285761
feediNg gUidelines infanT RandomIzEd coNtrolled Trial
NA
Recruiting
330 participants
Started: Mar 24, 2022 · Completed: Mar 31, 2027
1 condition
5 sponsors
1 location
NCT05307939
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
PHASE2
Recruiting
30 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2026
5 conditions
1 sponsor
7 locations
NCT04825990
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
PHASE2
Recruiting
30 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2028
1 condition
1 sponsor
1 location
NCT07103694
i-NEED: NEw migrainE Drugs Database
N/A
Recruiting
2,641 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05213572
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
N/A
Recruiting
200 participants
Started: Mar 24, 2022 · Completed: Jun 1, 2035
5 conditions
1 sponsor
1 location
NCT06250465
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
N/A
Recruiting
500 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
9 locations
NCT05569161
To Evaluate the Safety and Clinical Radiological Outcomes in 2 Years of Embrance Model Reverse Shoulder Arthroplasty
N/A
Recruiting
250 participants
Started: Mar 24, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT05323383
The Effects and Mechanisms of Brief Mindfulness Meditation and Hypnosis for Pain
NA
Recruiting
300 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT05287477
Passive Evaluation in Operational Environment of the AI Clinician Decision Support System for Sepsis Treatment
N/A
Recruiting
15 participants
Started: Mar 24, 2022 · Completed: Aug 31, 2024
1 condition
2 sponsors
2 locations
NCT06535451
Lung Cancer Screening Program in Mexico
N/A
Recruiting
1,000 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2027
1 condition
1 sponsor
1 location
NCT05216770
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
EARLY_PHASE1
Recruiting
165 participants
Started: Mar 24, 2022 · Completed: Aug 31, 2026
3 conditions
2 sponsors
1 location
NCT06144385
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
PHASE1
Recruiting
20 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05237245
Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
N/A
Recruiting
120 participants
Started: Mar 23, 2022 · Completed: Mar 31, 2027
3 conditions
1 sponsor
1 location
NCT05184803
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
PHASE2
Recruiting
63 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05241418
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
N/A
Recruiting
50 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2029
3 conditions
1 sponsor
1 location
NCT06501469
Biomarkers in Parkinsonian Syndromes
N/A
Recruiting
200 participants
Started: Mar 23, 2022 · Completed: Mar 25, 2030
5 conditions
2 sponsors
1 location
NCT05226117
Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
PHASE2
Recruiting
44 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT04713605
Cerebral Blood Flow in Neonates During Major Cardiac Surgery.
N/A
Recruiting
80 participants
Started: Mar 23, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05525338
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
PHASE4
Recruiting
196 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2026
5 conditions
7 sponsors
8 locations
NCT05227664
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
PHASE2
Recruiting
120 participants
Started: Mar 23, 2022 · Completed: Dec 30, 2026
2 conditions
1 sponsor
2 locations
NCT05346757
Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis
NA
Recruiting
5,390 participants
Started: Mar 23, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT05184842
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
PHASE2
Recruiting
85 participants
Started: Mar 23, 2022 · Completed: Mar 31, 2027
3 conditions
2 sponsors
3 locations
NCT05430490
Cannabis, HIV and Mental Processing Systems
N/A
Recruiting
320 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2026
2 conditions
2 sponsors
2 locations
NCT05329129
"OssDsign® Spine Registry Study (Propel)"
N/A
Recruiting
450 participants
Started: Mar 23, 2022 · Completed: Apr 1, 2027
2 conditions
1 sponsor
13 locations
NCT04257526
Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program
NA
Recruiting
500 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2024
1 condition
4 sponsors
1 location
NCT04021485
BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation
NA
Recruiting
643 participants
Started: Mar 23, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06254300
Online Exercise Program During Perioperative Treatment in Adults With Gastric Cancer
NA
Recruiting
40 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06342739
Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations
N/A
Recruiting
60 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05340361
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
N/A
Recruiting
30 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
3 conditions
3 sponsors
1 location
NCT05662722
Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear
NA
Recruiting
60 participants
Started: Mar 22, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT05321745
Fecal Microbiota Transplantation in Pediatric Crohn's Disease
NA
Recruiting
40 participants
Started: Mar 22, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06079827
Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients
N/A
Recruiting
43 participants
Started: Mar 22, 2022 · Completed: Sep 1, 2025
1 condition
1 sponsor
1 location
NCT04781192
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
PHASE1/PHASE2
Recruiting
40 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
5 locations
NCT05376254
3D Assessment of RV Function in Patients Undergoing LVAD Implantation
N/A
Recruiting
200 participants
Started: Mar 22, 2022 · Completed: Jan 19, 2027
1 condition
1 sponsor
1 location
NCT06343272
Lymphocyte Enhancement in Gastroenteric Oncology
NA
Recruiting
54 participants
Started: Mar 22, 2022 · Completed: Feb 28, 2025
1 condition
2 sponsors
1 location
NCT04831580
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NA
Recruiting
840 participants
Started: Mar 22, 2022 · Completed: Aug 31, 2029
1 condition
2 sponsors
136 locations
NCT05277051
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
PHASE1
Recruiting
141 participants
Started: Mar 22, 2022 · Completed: Sep 12, 2028
1 condition
1 sponsor
24 locations
NCT05322876
Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention
NA
Recruiting
80 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT05739253
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
N/A
Recruiting
480 participants
Started: Mar 22, 2022 · Completed: Mar 21, 2025
3 conditions
1 sponsor
1 location
NCT05277025
Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
N/A
Recruiting
150 participants
Started: Mar 22, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT05223790
Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.
N/A
Recruiting
50 participants
Started: Mar 22, 2022 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT05433545
Adherence to Physiotherapy Scoliosis Specific Exercises in Adolescents With Spine Deformity: Development of a New Questionnaire
N/A
Recruiting
600 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05001880
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
PHASE2
Recruiting
66 participants
Started: Mar 22, 2022 · Completed: Aug 20, 2026
1 condition
1 sponsor
39 locations
NCT05205356
VIGOR: Virtual Genome Center for Infant Health
N/A
Recruiting
750 participants
Started: Mar 22, 2022 · Completed: Mar 1, 2027
3 conditions
12 sponsors
9 locations
NCT05388474
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
N/A
Recruiting
200 participants
Started: Mar 22, 2022 · Completed: Jun 30, 2026
2 conditions
4 sponsors
36 locations
NCT05322343
Biobank and Brain Health in Bordeaux.
N/A
Recruiting
2,050 participants
Started: Mar 22, 2022 · Completed: Mar 22, 2030
15 conditions
1 sponsor
1 location
Previous
1
More pages
1009
1010
1011
1012
1013
1014
1015
More pages
1333
Next